Your browser doesn't support javascript.
loading
Barriers and facilitators of appropriate vancomycin use: prescribing context is key.
Chan, Joanne Oi Sze; Baysari, Melissa Therese; Carland, Jane Ellen; Sandaradura, Indy; Moran, Maria; Day, Richard Osborne.
Afiliación
  • Chan JOS; School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia. z3459011@unsw.edu.au.
  • Baysari MT; Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, NSW, Australia. z3459011@unsw.edu.au.
  • Carland JE; Australian Institute of Health Innovation, Macquarie University, North Ryde, NSW, Australia.
  • Sandaradura I; Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, NSW, Australia.
  • Moran M; School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
  • Day RO; Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, NSW, Australia.
Eur J Clin Pharmacol ; 74(11): 1523-1529, 2018 Nov.
Article en En | MEDLINE | ID: mdl-30056569
ABSTRACT

PURPOSE:

Audit studies reveal frequent non-compliance with dosing and monitoring guidelines for vancomycin. This study aimed to qualitatively explore the barriers and facilitators of compliance with vancomycin dosing and monitoring guidelines.

METHODS:

Interviews were conducted with 16 prescribers in a large tertiary teaching hospital in Sydney, Australia. Questions explored knowledge, attitudes, and perceived complexities associated with vancomycin use. Interviews were analysed using thematic analysis.

RESULTS:

Prescribers reported utilising vancomycin guidelines, citing familiarity with guidelines, a positive perception of guidelines, awareness of poor guideline compliance, and assistance from specialist staff as facilitators of the uptake of guideline recommendations. Barriers existing within the prescribing environment such as the prescribing culture, a lack of time, and poor communication and coordination of therapeutic drug monitoring processes were identified as hindrances to guideline compliance.

CONCLUSIONS:

The provision of guidelines may not be sufficient in ensuring appropriate prescribing and monitoring of vancomycin when barriers relating to the prescribing environment exist. Developing interventions targeted toward these barriers, such as having dedicated phlebotomists for vancomycin blood sampling, fostering better handover processes, and educating staff on poorly understood aspects of guidelines, is likely to improve the uptake of guideline recommendations for vancomycin and other medications requiring therapeutic drug monitoring.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pautas de la Práctica en Medicina / Vancomicina / Monitoreo de Drogas / Antibacterianos Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Límite: Female / Humans / Male País/Región como asunto: Oceania Idioma: En Revista: Eur J Clin Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pautas de la Práctica en Medicina / Vancomicina / Monitoreo de Drogas / Antibacterianos Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Límite: Female / Humans / Male País/Región como asunto: Oceania Idioma: En Revista: Eur J Clin Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Australia